Both the FTC and Congress want to rein in pharmacy benefit managers (PBMs), as they focus on alleged anti-competitive practices which hinder a properly functioning prescription drug market. Maybe this time an inquiry and legislative action will happen, as there’s considerable bipartisan support.
Subscribe to:
Post Comments (Atom)
< + > Why Healthcare Needs Coordinated Infrastructure, Not More Point Solutions
Cotiviti ties together providers and payers, including the top 25 US health plans, that collectively serve 300 million members in the Unite...
No comments:
Post a Comment